经尿道等离子体电切术治疗高龄高危前列腺增生症的体会

目的：探讨经尿道等离子体双极电极汽化电切术（TUPKVP）治疗高龄高危前列腺增生症（BPH）的安全性及疗效。方法：采用TUPKVP治疗高龄高危BPH患者61例。结果：手术切除前列腺重量（14．1～90．0）g，平均53g，出血量30～100ml，未出现TURS、真性尿失禁，术中、术后无输血，所有患者术后均排尿通畅，随访3～12个月，IPSS评分由术前（22．4±4．2）分，降至术后（7.2±3．3）分。结论：TUPKVP是高龄高危BPH的安全有效的治疗方法，TUPKVP的汽化止血效果更好．更能减少TURS的发生，对高龄高危的BPH患者安全性更高。

Experience on treatment of a dvanced age and danger benign prostatic hyperplasia(BPH)patients with transurethral plasmakinetic resection of prostate

Objective： To evaluate the effect and safety of surgical treatment of transurethral plasmakinetic resection of prostate （TUPKVP）in advanced age and danger of benign prostatic hyperplasia （BPH） patients. Methods：61 cases of BPH were treated by transurethral plasmakinetic resection of prostate （TUPKVP）. Results： The mean prostatic weight was 53 g and blood loss 30 to 100 ml. No TURS and no real urinary incontinence and no blood transfusion. All cases obtained un- obstructed micturition after treatment. Following up 3 to 12 months, their international prostate symptom score （IPSS） were significantly improved by TUPKVP. Conclusion： TUPKVP is a safe and effective way in the treatment of advaneed age and danger benign prostatic hyperplasia（BPH） patients.